LXRX - Lexicon Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LXRX is currently covered by 1 analysts with an average price target of $2.92. This is a potential upside of $2.21 (311.27%) from yesterday's end of day stock price of $0.71.

Lexicon Pharmaceuticals's activity chart (see below) currently has 38 price targets and 35 ratings on display. The stock rating distribution of LXRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.14% with an average time for these price targets to be met of 74 days.

Highest price target for LXRX is $3, Lowest price target is $1, average price target is $2.92.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 12-Dec-2023. First documented stock forecast 11-Oct-2013.

Currently out of the existing stock ratings of LXRX, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$4

$2.73 (214.96%)

$8

1 years 10 days ago
(12-Dec-2023)

4/15 (26.67%)

$2.82 (238.98%)

47

Buy

$10

$8.73 (687.40%)

$10

2 years 2 months 19 days ago
(03-Oct-2022)

0/2 (0%)

$7.55 (308.16%)

Hold

$7

$5.91 (542.20%)

3 years 10 months 23 days ago
(29-Jan-2021)

3/3 (100%)

$1.33 (13.05%)

55

Buy

$2

$0.73 (57.48%)

3 years 10 months 23 days ago
(29-Jan-2021)

2/6 (33.33%)

$-5.91 (-74.72%)

409

Hold

3 years 11 months 7 days ago
(15-Jan-2021)

1/1 (100%)

$0.8 (36.36%)

7

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LXRX (Lexicon Pharmaceuticals) average time for price targets to be met?

On average it took 74 days on average for the stock forecasts to be realized with a an average price target met ratio 37.14

Which analyst has the current highest performing score on LXRX (Lexicon Pharmaceuticals) with a proven track record?

JESSICA FYE

Which analyst has the current lower performing score on LXRX (Lexicon Pharmaceuticals) with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on LXRX (Lexicon Pharmaceuticals)?

Jessica Fye works at JPMORGAN and has 12 price targets and 6 ratings on LXRX

Which analyst is the currently most bullish on LXRX (Lexicon Pharmaceuticals)?

Yasmeen Rahimi with highest potential upside - $8.73

Which analyst is the currently most reserved on LXRX (Lexicon Pharmaceuticals)?

Stephen Willey with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?